FIVE New KdVSF Investigator Grants

Global Genes asked Global Advocacy Alliance members to share their successes – whether it is meeting an organizational goal, kicking off a campaign or event, conducting great work in their community, participating at a summit, or collaborating with another organization. See what Koolen-de Vries Syndrome Foundation is celebrating!

Ashley Point
Koolen-de Vries Syndrome Foundation

The Koolen-de Vries Syndrome (KdVS) Foundation is pleased to announce that it has awarded five 2024 Investigator Grants to fund translational research that will accelerate the development of treatments for individuals with KdVS. The researchers were awarded between $40,000-$57,000 each.

The researcher and their titled project are listed below:

• Dr. Helen Willsey, UCSF, “The Role of Kansl1 in Cilia”
• Dr. Jordan Wright, Murdoch Children’s Research Institute, “Exploring the therapeutic potential of histone acetylation modifying compounds in human neuronal models of KdVS”
• Dr. Victor Faundez, Emory University, “Systemic Molecular Phenotypes in KdVS”
• Drs. David Koolen and Bert de Vries, Radboud UMC, “The Natural history in KdVS: an initial step towards personalized treatment”
• Dr. Yann Herault, Institut de génétique et de biologie moléculaire et cellulaire, “RESKAN: Rescue Kansl1 Haploinsufficiency during early lifetime”